• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume9, Issue4

STUDIES ON PAROTID GLAND NEOPLASMAS USING FINE NEEDLE ASPIRATION CYTOLOGY

    Dr G Prathima, Dr N. Sailarekha

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 4, Pages 2825-2838

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

The most common target organs where fine needle aspiration cytology (FNAC) is performed are salivary glands because of their superficial location and easy accessibility introduced into a mass, cellular material is aspirated, and a cytological diagnosis is rendered as It separates reactive and inflammatory processes that do not require surgical intervention from neoplasia and benign from malignant tumors.
OBJECTIVES:
To study the cytomorphological features in lesions of salivary glands. To correlate the cytological features with histopathological features wherever possible. To evaluate the diagnostic utility of fine needle aspiration cytology of lesions in the salivary glands.
METHODOLOGY:
A total of 120 patients with salivary gland diseases were included in the study. This is a retrospective cohort study, undertaken in the Department of Pathology, Fathima Institute of Medical sciences, Kadapa during the period of Jan 2016 to Feb 2020. The sensitivity, specificity and overall diagnostic accuracy was calculated using Galen and Gambino method.
RESULTS:
Our study included 120 patients with salivary gland diseases. Age group of patients with salivary gland diseases ranged from 10 years to 88 years with the mean age of 44.62 years. Majority of the patients belonged to the age group of 31-40 years (35%). Male to Female ratio was 1.25: 1. Among the 120 patients, most common non neoplastic 67.52%, benign 71.79% and malignant 28.20% lesions.
CONCLUSION:
FNAC of salivary gland is a reliable and sensitive diagnostic method for diagnosis of salivary gland lesions. It not only provides preoperative diagnosis for management but also can prevent unnecessary surgeries.
Keywords:
    Fine needle aspiration cytology (FNAC) Salivary gland lesions diagnostic accuracy Sensitivity Specificity
  • PDF (916 K)
  • XML
(2022). STUDIES ON PAROTID GLAND NEOPLASMAS USING FINE NEEDLE ASPIRATION CYTOLOGY. European Journal of Molecular & Clinical Medicine, 9(4), 2825-2838.
Dr G Prathima, Dr N. Sailarekha. "STUDIES ON PAROTID GLAND NEOPLASMAS USING FINE NEEDLE ASPIRATION CYTOLOGY". European Journal of Molecular & Clinical Medicine, 9, 4, 2022, 2825-2838.
(2022). 'STUDIES ON PAROTID GLAND NEOPLASMAS USING FINE NEEDLE ASPIRATION CYTOLOGY', European Journal of Molecular & Clinical Medicine, 9(4), pp. 2825-2838.
STUDIES ON PAROTID GLAND NEOPLASMAS USING FINE NEEDLE ASPIRATION CYTOLOGY. European Journal of Molecular & Clinical Medicine, 2022; 9(4): 2825-2838.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 45
  • PDF Download: 41
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus